Alkem Laboratories Limited — Board Meeting, 13-11-2025: Outcome of Board Meeting
13-11-2025 | 01:51 pm
13-11-2025 | 01:51 pm
Alkem Labs' Q2 FY26 consolidated revenue surged 17.2% YoY to ₹4,001 Cr. EBITDA grew 22.3% to ₹920.8 Cr (23% margin), with net profit up 11.1% to ₹765.1 Cr. Strong growth across India & international markets. #Alkem #Earnings
No comments yet. Be the first to comment!
